Summary A detailed study was performed in 14 patients with epithelial ovarian tumours using the satellite probes 33.15, 228S and 216S to investigate the nature of somatic changes and frequency with which clonal changes could be demonstrated during metastasis and progression. Somatic changes were evident in approximately 70% of ovarian tumours, the most common being a deletion or reduction in intensity of a band suggesting loss of heterozygosity. Additional changes that were observed included increased intensification of single bands and the appearance of novel DNA fragments. Somatic alterations were seen following digestion of DNA with methylation resistant restriction endonucleases indicating that methylation differences alone could not account for all of the somatic changes. Using DNA fingerprint analyis ovarian tumours were shown to be heterogeneous with different DNA patterns observed in different sites in five of eight patients. Generally, within an individual patient the primary and metastases appeared to share a DNA fingerprint pattern with minor variations occurring in different sites suggesting that different populations have derived from a common stem line. This study clearly demonstrates that DNA fingerprint analysis is a sensitive method to detect somatic changes in tumour DNA and for investigating the development of clonal heterogeneity in ovarian tumours.
Ovarian cancer is a major cause of female cancer deaths yet relatively little is known of the genetic events associated with the development or subsequent metastasis and progression of epithelial ovarian tumours. Complex karyotypic changes have been observed, and although certain non-random abnormalities have been reported (Wake et al., 1980; WhangPeng et al., 1984) in particular involving 6q -and 14q +, these have not been confirmed in subsequent studies and no unique or consistent chromosomal abnormality has been identified. Cytogenetic analysis has revealed a high incidence of structural as well as numerical changes that are reflected in alterations in tumour cellular DNA content (Jakobsen et al., 1983) , which in turn has been shown to reflect the biological behaviour of ovarian tumours (Friedlander et al., 1984 (Friedlander et al., , 1988 . Diploid ovarian tumours tend to be more indolent than aneuploid tumours, and are associated with a more favourable prognosis, but the reasons for this variability in biological behaviour are not understood (Friedlander et al., 1984) . Detailed studies into oncogene activation and deregulation in ovarian cancer have largely been unrewarding and although amplification or increased expression of several oncogenes, in particular C-Ki-ras, has been reported, the incidence is low and significance probably secondary (Boltz et al., 1989 ; Van't Veer et al., 1988) . Gene loss has recently been implicated in the development and progression of a wide range of human tumours, including the common solid tumours such as breast, lung and colon cancer (Ponder, 1988; Hansen & Cavanee, 1988 (Jeffreys et al., 1985) . DNA fingerprints demonstrate both somatic and germ line stability and being completely individual specific makes them particularly useful in criminal identification and parenthood disputes. Minisatellite probes consisting of the core sequence repeated in the tandem recognise sequences present on the majority of human chromosomes rather than on a single chromosome and provide a set of genetic markers which are also of value in detecting somatic changes in tumour DNA (Thein et al., 1987; Fey et al., 1988 (Fowler et al., 1988 The labelled probes were hybridised with the nylon filters in 4 x SSPP, 0.5% instant skimmed milk powder ('blotto') and 1% SDS at 65°C overnight. The filters were washed in four successive washes of 2 x SSC, 0.1 % SDS for 15 minutes at 37°C; 0.5 x SSC, 0.1% SDS + 150tl' Proteinase K (20 mg ml-') for 60 minutes at 37°C; 0.1 x SSC, 0.1% SDS for 30 minutes at 37°C; 0.1 x SSC, 1% SDS for 30 minutes at 55°C. Filters were exposed to Kodak X-ray film overnight without intensifying screens.
Results
Multiple tumour samples and corresponding constitutional DNA from 14 patients with ovarian tumours were analysed using the mini and macrosatellite probes 33.15 and 228S respectively. Complex banding patterns were obtained and up to 42 resolvable hypervariable fragments ranging from 23 to 2 kb in size could be detected using either probe. The DNA 'fingerprint' obtained for each patient was discriminating and individual specific. The detailed results and comparison of the banding patterns observed in tumour DNA and corresponding constitutional DNA are summarised in Table II . Differences between tumours and corresponding constitutional DNA that were observed included: (a) a deletion or decrease in relative intensity of a band, (b) the appearance of novel fragments, and (c) amplification or a significant increase in relative intensity of a band. Somatic changes could be demonstrated in most tumours and a difference in the banding pattern in tumour DNA was evident in 10 of the 14 patients. The most common variation was a deletion or shift in the relative intensity of a band/s and this was apparent in nine of the 14 cases. A relative increase in band intensity or amplification was demonstrated in tumours from six patients while novel fragments were detected in five ovarian carcinomas. The DNA fingerprint pattern depended on the satellite probe as well as the restriction enzyme used to digest the DNA. Results using 228S/Taq 1 and 33.15/Hinf 1 were often quite different (see Table II ), but were complementary and additional information was obtained using both probes. However, all tumours which were probed with 228S/Taq 1 and shown not to differ from corresponding constitutional DNA were also normal using 33.15/Hinf 1.
Tumours and constitutional DNA were digested with Alu 1 and/or Hae III and probed with 33.15 to determine whether the apparent somatic changes were due to specific DNA methylation which could affect Hinf 1 cleavage sites. With one exception, changes in the tumour DNA fingerprints were observed in all tumours that had somatic alterations demonstrated with 33.15/Hinf 1. However, in four of the cases at least some of the alterations in relative band intensity that were observed with 33.15/Hinf 1 appeared to be related to DNA methylation changes. For example, in patient BE there was an apparent reduction in intensity in a 3.8 kb band in all tumour sites, an additional reduction in intensity of a 5.5 kb band in a peritoneal metastasis and the appearance of three new bands in a rectal metastasis when DNA was digested Hinf 1 and probed with 33.15 (Table II, Figure la) . The DNA pattern obtained following digestion with Alu 1 showed no evidence of deletion of any bands apart from reduction in intensity of a 6 kb band in the peritoneal metastasis, but confirmed the presence of multiple new bands in the rectal metastasis (Figure lb) .
The Hae III digest demonstrated the presence of two new bands and reduction in intensity of two bands in the rectal metastasis, but no changes were evident in the other sites.
The stability of the somatic changes in multiple tumour sites could be investigated in seven informative patients in whom the tumour DNA differed from constitutional DNA and where more than one metastatic site was sampled in addition to the primary. In five such cases (BE, GR, GA, NO, AM) there was evidence of variability in the DNA fingerprint pattern in different tumour sites within the same patient, while in two patients (TA, DO) all the tumour sites sampled shared somatic alterations in common with the primary site (Table II) . Generally the differences observed were with alterations evident in only one or two bands in one or more metastatic sites. However, a particular striking example of tumour heterogeneity was observed in patient BE in whom multiple new bands were observed in a solitary rectal metastasis and deletion of a band in a peritoneal metastasis (Figure la and b) . The histological sections in this case were carefully reviewed and despite the differences at the genomic level in different metastatic sites the tumour biopsies all appeared to be histological identical.
Tumours and constitutional DNA from all patients were digested with Pst 1 and probed with 216S, a satellite III DNA probe which gives an invariate banding pattern, in order to determine whether common non-random deletions could be detected (Figure 2 ). However, providing that digestion was complete there appeared to be no differences observed in the majority of tumours and an identical banding pattern was obtained in all cases apart from two tumours with an apparent reduction in intensity of a single common band. given in kilobase pairs (constitutional DNA is represented by normal uterine muscle). In a there is reduction in intensity of a 3.8 kb band in all sites, an additional reduction in intensity of a 5.5 kb band in a (peritoneal) metastasis and the appearance of three new bands in a rectal metastasis. DNA was digested with Alu I and probed with 33.15 (b) to determine whether the apparent somatic changes were due to DNA methylation which could cleave Hinf I cleavage sites. There was reduction in intensity of a 6 kb band in the peritoneal metastasis and evidence of new bands in the rectal metastasis. (Ponder, 1988; Hansen & Cavanee, 1988 (Frost & Kerbel, 1981; Razin & Riggs, 1980) . Demethylation could certainly lead to gene activation and account for many of the changes associated with tumour progression without necessarily invoking genomic rearrangements, but its relative significance remains to be established.
Discussion
It is not known whether the somatic changes that we have observed using DNA fingerprint analysis are fundamental to the pathogenesis and progression of ovarian tumours or are merely epiphenomena reflecting the accumulating genetic defects that occur with tumour progression. Furthermore, due to the polymorphic nature of the probes it is not possible to determine which, if any, of the changes are non-random. An attempt was made to screen for the presence of nonrandom events using one of a new series of so-called 'invariate' repetitive DNA probes. Unlike the multivariate minisatellite probes this class of probe recognises bands of consistent restriction fragment length throughout the population (Fowler et al., 1988) . Apart from two cases, the banding pattern with invariate probes was identical in all the tumour and constitutional DNA samples. Although this approach did not appear to be informative it does not of course rule out the possibility of common non-random genetic changes occurring in ovarian tumours. Cytogenetic analysis has demonstrated the heterogeneous nature of ovarian tumours, but due to technical limitations it has not generally been possible to study both the primary tumour and multiple metastatic sites in the same patient.
DNA fingerprint analysis, however, is well suited to investigation of clonal evolution and heterogeneity within a neoplastic cell population. Using this technique ovarian tumours are demonstrably heterogeneous with different DNA patterns observed in different sites. Changes in relative band intensity were accompanied by loss as well as acquisition of fragments in different sites, and this observation is more consistent with numerical or structural chromosomal differences in different sites than with inclusion of different amounts of tumour tissue in the biopsy specimens. Generally, within an individual patient, the primary tumour and metastases appear to share a common DNA fingerprint pattern with minor variations occurring in different sites, suggesting that the different populations are derived from a common stem cell. This is in keeping with the hypothesis that tumour progression results from acquired genetic variability within the original malignant cell population, with sequential selection of increasingly genetically altered, and possibly more aggressive, subpopulations (Nowell, 1976 ). An alternative explanation to account for the heterogeneous nature of ovarian tumours is that ovarian tumours may, in some instances, be multifocal in origin, with tumorigenesis occurring within a field defect in coelomic epithelium and mesenchyme, (Woodruff & Julian, 1969) resulting in the development of multiple synchronous primary tumours with a different genetic make-up. Tumours arising in this fashion would be expected to show a high degree of site-to-site variability on DNA fingerprint analysis and this is therefore not fully supported by the relatively minor variations demonstrated in the majority of patients in the study. However, the number of patients in this study is ,oo few to refute the possibility of multifocal tumorigenesis occurring in a proportion of patients with widespread gynaecological neoplasia. The identification of patients with 'extensive disease' as a result of carcinogenesis occurring in a field defect should be pursued and DNA fingerprint analysis could prove to be useful in this regard.
This study clearly demonstrates that DNA fingerprint analysis is a sensitive method to detect somatic changes in tumour DNA and for investigating the development of clonal heterogeneity in ovarian tumours. The most frequent abnormality observed was a deletion or decrease in intensity of a band suggesting loss of heterozygosity and as a natural extension of the study we are now attempting to isolate and clone the fragments present in constitutional DNA that have been deleted in corresponding tumour DNA in selected patients. This strategy has previously been successful and a large hypervariable DNA fragment from a human DNA fingerprint has recently been isolated, purified and cloned (Wong et al., 1986) . The fragment contained multiple copies of a 37 bp repeat unit but was flanked by non-repetitive unique sequence DNA that hybridised to a single locus on chromosome 7 and which has subsequently been used to detect chromosome 7 loss in myelodysplasia (Thein et al., mo 1988 ). It should therefore be possible to obtain locus-specific hybridisation probes by isolating and cloning selected fragments in DNA fingerprints obtained from patients with ovarian tumours and to use these probes to determine the frequency and biological significance of genomic rearrangements at these various loci in a larger cohort of patients with ovarian cancer.
